Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

Author:

Yang Jiannan1,Li Zhen2,Wu William Ka Kei3ORCID,Yu Shi45ORCID,Xu Zhongzhi1,Chu Qian6,Zhang Qingpeng1ORCID

Affiliation:

1. School of Data Science, City University of Hong Kong , Hong Kong SAR , China

2. Department of Radiology, Tongji Hospital, Huazhong University of Science and Technology , Wuhan , China

3. Department of Anaesthesia and Intensive Care, Chinese University of Hong Kong , Hong Kong SAR , China

4. The USC Norris Center for Cancer Drug Development, University of Southern California , Los Angeles, CA , USA

5. Keck School of Medicine, University of Southern California , Los Angeles, CA , USA

6. Department of Thoracic Oncology, Tongji Hospital, Huazhong University of Science and Technology , Wuhan , China

Abstract

Abstract The discovery and repurposing of drugs require a deep understanding of the mechanism of drug action (MODA). Existing computational methods mainly model MODA with the protein–protein interaction (PPI) network. However, the molecular interactions of drugs in the human body are far beyond PPIs. Additionally, the lack of interpretability of these models hinders their practicability. We propose an interpretable deep learning-based path-reasoning framework (iDPath) for drug discovery and repurposing by capturing MODA on by far the most comprehensive multilayer biological network consisting of the complex high-dimensional molecular interactions between genes, proteins and chemicals. Experiments show that iDPath outperforms state-of-the-art machine learning methods on a general drug repurposing task. Further investigations demonstrate that iDPath can identify explicit critical paths that are consistent with clinical evidence. To demonstrate the practical value of iDPath, we apply it to the identification of potential drugs for treating prostate cancer and hypertension. Results show that iDPath can discover new FDA-approved drugs. This research provides a novel interpretable artificial intelligence perspective on drug discovery.

Funder

National Natural Science Foundation of China

Innovation and Technology Fund of Innovation and Technology Commission of Hong Kong

National Key Research and Development Program of China

Ministry of Science and Technology of China

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3